Swiss Competition Commission (COMCO) announced on October 10 that it has terminated the investigation into Novartis, with no consequences. On September 13, 2022, the Commission initiated an investigation into Novartis to determine if the company intended to illegally protect one of its skin disease drugs by filing various patent infringement lawsuits. The investigation results indicated that Novartis' actions are common practices in the field of patent law and did not show any signs of illegal competition restrictions. Therefore, the Swiss Competition Commission terminated the investigation.
瑞士反垄断监管机构结束对诺华调查
Swiss Competition Commission (COMCO) announced on October 10 that it has ended the investigation into Novartis without any consequences.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated